Alex's Lemonade Stand Foundation Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2017
NCT02439788
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Alex's Lemonade Stand Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Disease (Phase 1)

Blast Crisis (Phase 1)

Leukemia (Phase 1)

Leukemia, Biphenotypic, Acute (Phase 1)

Leukemia, Lymphoid (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Leukemia, Myelomonocytic, Acute (Phase 1)

Leukemia, Myelomonocytic, Chronic (Phase 1)

Leukemia, Myelomonocytic, Juvenile (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Neoplasms (Phase 1)

Neuroblastoma (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Preleukemia (Phase 1)

Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 4